251 related articles for article (PubMed ID: 19691205)
1. Horizons: the 2009 table clinics.
Thumbigeremath V
Northwest Dent; 2009; 88(3):33-4, 87. PubMed ID: 19691205
[No Abstract] [Full Text] [Related]
2. Staging bisphosphonate-related osteonecrosis of the jaw should include early stages of disease.
McMahon RE; Bouquot JE; Glueck CJ; Griep JA; Adams WR; Spolnik KJ; Deardorf KA
J Oral Maxillofac Surg; 2007 Sep; 65(9):1899-900. PubMed ID: 17719423
[No Abstract] [Full Text] [Related]
3. Osteonecrosis of the jaw associated with bisphosphonate therapy.
Wirth SM; Lawson AP; Sutphin SD; Adams VR
Orthopedics; 2009 Dec; 32(12):900. PubMed ID: 20000241
[No Abstract] [Full Text] [Related]
4. Why osteonecrosis of the jaw after bisphosphonates treatment is more frequent in multiple myeloma than in solid tumors.
Delibasi T; Altundag K; Kanlioglu Y
J Oral Maxillofac Surg; 2006 Jun; 64(6):995-6. PubMed ID: 16713825
[No Abstract] [Full Text] [Related]
5. Lingual mucosal ulceration with mandibular sequestration (Dent Update 2007; 34: 573-577).
Dhanrajani PJ
Dent Update; 2008 Nov; 35(9):642. PubMed ID: 19068522
[No Abstract] [Full Text] [Related]
6. Nonexposed bisphosphonate-related osteonecrosis of the jaws: another clinical variant?
Junquera L; Gallego L
J Oral Maxillofac Surg; 2008 Jul; 66(7):1516-7. PubMed ID: 18571043
[No Abstract] [Full Text] [Related]
7. Bisphosphonates, hypercalcemia of malignancy, and osteonecrosis of the jaw.
Wynn RL
Gen Dent; 2005; 53(6):392-5. PubMed ID: 16366043
[No Abstract] [Full Text] [Related]
8. [Bisphosphonates and osteonecrosis of the jaw].
Saussez S; Filleul O; Loeb I
Rev Stomatol Chir Maxillofac; 2008 Dec; 109(6):367-73. PubMed ID: 19013624
[TBL] [Abstract][Full Text] [Related]
9. Bisphosphonate related osteonecrosis of the jaws.
Fung E
J Rheumatol; 2009 Feb; 36(2):450; author reply 453. PubMed ID: 19208578
[No Abstract] [Full Text] [Related]
10. [Osteonecrosis of the jaw].
Eriksen EF
Ugeskr Laeger; 2009 Feb; 171(8):629; author reply 629. PubMed ID: 19291862
[No Abstract] [Full Text] [Related]
11. Osteonecrosis of the jaw.
Sykes DL
Dent Today; 2007 Feb; 26(2):16. PubMed ID: 17348272
[No Abstract] [Full Text] [Related]
12. Osteonecrosis of the jaw and the use of antiangiogenic agents: just an association?
Aragon-Ching JB; Dahut WL
Oncologist; 2008 Dec; 13(12):1314; author reply 1315. PubMed ID: 19088325
[No Abstract] [Full Text] [Related]
13. Bisphosphonate associated osteonecrosis of the jaw; similarities and differences in oncologic and non-oncologic patients.
Chogle AR
J Assoc Physicians India; 2011 Aug; 59():477-8. PubMed ID: 21887901
[No Abstract] [Full Text] [Related]
14. Jaw osteonecrosis related to bisphosphonates: a new concern for dentistry.
Geist RY; Geist JR; Aksu M
J Mich Dent Assoc; 2005 Nov; 87(11):40-2. PubMed ID: 16372547
[No Abstract] [Full Text] [Related]
15. Osteonecrosis: what dentists need to know.
Thoman RD
Hawaii Dent J; 2006; 37(6):9-10, 12-3. PubMed ID: 17290948
[No Abstract] [Full Text] [Related]
16. The science of bisphosphonate-related osteonecrosis of the jaws: the thin white line.
Assael LA
J Oral Maxillofac Surg; 2007 Jul; 65(7):1275-6. PubMed ID: 17577488
[No Abstract] [Full Text] [Related]
17. Osteonecrosis of the jaw in a patient treated with ibandronate.
Vomvas D; Vassiliou V; Papavasileiou D; Kalogeropoulou C; Nicolatou-Galitis O; Kardamakis D
J BUON; 2008; 13(3):441-2. PubMed ID: 18979566
[No Abstract] [Full Text] [Related]
18. The tip of the iceberg.
Felsenfeld AL
J Calif Dent Assoc; 2005 Oct; 33(10):765-6. PubMed ID: 16350878
[No Abstract] [Full Text] [Related]
19. The bisphosphonates struggle.
Johnston JW
J Mich Dent Assoc; 2006 Oct; 88(10):12. PubMed ID: 17078336
[No Abstract] [Full Text] [Related]
20. Low-down on link between bone-builders and jaw damage.
Johns Hopkins Med Lett Health After 50; 2006 Sep; 18(7):1-2. PubMed ID: 17120363
[No Abstract] [Full Text] [Related]
[Next] [New Search]
